PL330191A1
Soluble oxides for biological applications
Abstract
The present invention is concerned with the use of a silica-xerogel, prepared via a sol-gel process, dissolving totally during a desired period when in contact with body fluids, and incorporated with a biologically active agent, for the manufacture of a delivery device for controlled release delivery of the biologically active agent.
Term
Term ended
Projected expiry passed 29 May 2017, 9.3 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
44 members in 19 offices
Priority claims12
| Document | Office | Kind | Date |
|---|---|---|---|
| 1857596 | United States of America | P | |
| 1857596 | United States of America | P | |
| 4242397 | United States of America | P | |
| 4242397 | United States of America | P | |
| 9700330 | Finland | W | |
| 9700330 | Finland | W | |
| 60018575 | – | – | – |
| 60042423 | – | – | – |
| FI9700330 | – | – | – |
| US19960018575P | – | – | – |
| US19970042423P | – | – | – |
| WO1997FI00330 | – | – | – |
Members44
| Document | Office | Kind | |
|---|---|---|---|
| CA2257172A1 | Canada | A1 | |
| WO9745367A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2964197A | Australia | A | |
| NO985534D0 | Norway | D0 | |
| NO985534L | Norway | L | |
| EP0906243A1 | European Patent Office (EPO) | A1 | |
| PL330191A1This record | Poland | A1 | |
| CN1219919A | China | A | |
| CZ384598A3 | Czechia | A3 | |
| EE9800418A | Estonia | A | |
| SK164298A3 | Slovakia | A3 | |
| HU9903865A2 | Hungary | A2 | |
| HUP9903865A1 | Hungary | A1 | |
| HU9903865A3 | Hungary | A3 | |
| HUP9903865A3 | Hungary | A3 | |
| NZ332968A | New Zealand | A | |
| JP2001509122A | Japan | A | |
| AU738176B2 | Australia | B2 | |
| EE03758B1 | Estonia | B1 | |
| US2003021820A1 | United States of America | A1 | |
| CN1103320C | China | C | |
| RU2208582C2 | Russian Federation | C2 | |
| US6764690B2 | United States of America | B2 | |
| SK284193B6 | Slovakia | B6 | |
| US2004197414A1 | United States of America | A1 | |
| CA2257172C | Canada | C | |
| EP0906243B1 | European Patent Office (EPO) | B1 | |
| AT301102T | Austria | T | |
| ATE301102T1 | Austria | T1 | |
| DE69733889D1 | Germany | D1 | |
| DK0906243T3 | Denmark | T3 | |
| ES2244998T3 | Spain | T3 | |
| EP1618896A2 | European Patent Office (EPO) | A2 | |
| DE69733889T2 | Germany | T2 | |
| CZ297042B6 | Czechia | B6 | |
| US7326422B2 | United States of America | B2 | |
| EP0906243B2 | European Patent Office (EPO) | B2 | |
| DK0906243T4 | Denmark | T4 | |
| ES2244998T5 | Spain | T5 | |
| JP4322315B2 | Japan | B2 | |
| DE69733889T3 | Germany | T3 | |
| NO328711B1 | Norway | B1 | |
| EP1618896A3 | European Patent Office (EPO) | A3 | |
| HU227939B1 | Hungary | B1 |
Numbers
- Publication, DOCDB
- 330191
- Publication, EPODOC
- PL330191
- Application
- 97330191
- Application, DOCDB
- 33019197
- Application, EPODOC
- PL19970330191
Titles
- English
- SOLUBLE OXIDES FOR BIOLOGICAL APPLICATIONS
Classification
- CPC, 19
- A61K9/0019
- A61K9/06
- A61K9/1676
- A61K47/02
- A61L24/0015
- A61L24/0031
- A61L24/0042
- A61L24/02
- A61L27/10
- A61L27/52
- A61L27/54
- A61L27/58
- A61L2300/252
- A61L2300/30
- A61L2300/416
- A61L2300/43
- A61L2300/602
- A61L2300/64
- C01B33/163
- IPC, 3
- A61K9 06
- A61K47 02
- C01B33 16